InvestorsHub Logo
Followers 129
Posts 23648
Boards Moderated 1
Alias Born 09/14/2016

Re: None

Tuesday, 02/15/2022 9:54:40 AM

Tuesday, February 15, 2022 9:54:40 AM

Post# of 632
Avalon GloboCare Corp (NASDAQ: $AVCO) is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-NK) cell therapies. https://finance.yahoo.com/news/avalon-globocare-adds-car-nk-165721173.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALBT News